WithdrawnPhase 2

Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation

Stopped: As the inclusion period in the study has ended and regulatory authorizations have expired on 26/12/2023, with no inclusions conducted.

France0Started 2023-12

Plain-language summary

The purpose of this study is to evaluate, in patients presenting with out-of-hospital cardiac arrest (OHCA) by ventricular fibrillation, refractory to 3 external electric shocks, the efficacy of a direct intravenous injection of 20 mmol KCl on their survival at hospital arrival.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patient (age 18 or over). * Patient suffering from an outpatient cardiac arrest of presumed cardiac origin and presenting refractory ventricular fibrillation despite 3 external electric shocks. * Patient with a health insurance plan. Exclusion Criteria: * Proven pregnancy. * Major incompetent (patient under guardianship or curatorship). * Patient who does not yet have a functional venous pathway after the 3 external electric shocks have been performed.

What they're measuring

Survival at hospital admission

Timeframe: At hospital admission up to 1 day

Trial details

NCT IDNCT04316611

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

View on ClinicalTrials.gov More Out-of-hospital Cardiac Arrest (OHCA) trials